The customer observed false negative b-hcg result on the architect i2000sr analyzer.The following data was provided (miu/ml): (b)(6): initial 1.57, repeats 27.43, 25.03, initial 36.03, repeat 33.75.There was no impact to patient management reported.
|
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, review of instrument logs, a review of labeling, review of field data and accuracy testing.This review showed increased complaint activity for product lot 81083ui00 related to false positive patient results.There was no increase in complaint activity for false depressed patient results, and no adverse trend was identified.Labeling was reviewed and found to be adequate.The product was not available for return.Historical performance of the reagent lot was evaluated using world wide data.The patient data was analyzed and within established control limits and there is no systemic issue for this lot.An internal panel was tested with retained kits of the likely cause reagent lot and accuracy testing met all specifications.Based on all available information and abbott diagnostics' complaint investigation no product deficiency was identified.
|